Uveal Melanoma
Ireland has possibly highest incidence in the world


Priscilla Lynch
Published: Thursday, September 1, 2016

SYSTEMIC TREATMENTS
Treatments modalities during the course of the study included brachytherapy (63.7 per cent), enucleation of the affected eye (27 per cent) and proton beam radiation (9.2 per cent). Chromosome 3 loss and chromosome 8q gain were identified in 29.3 per cent and 29.7 per cent of cases, respectively. Dr Baily noted that uveal melanoma survival rates are good in Ireland — one-year survival was 95.8 per cent and four-year survival was 84.0 per cent in the study patient population. “Despite the different treatment options available, overall survival in uveal melanoma has not improved. Ultimately we need the development of systemic treatments to improve overall survival rates,” Dr Baily said.CILIARY BODY
Uveal melanoma is the most common primary intraocular malignancy in adults, and involves the iris, ciliary body, or choroid. Despite this, it is still a very rare disease, Dr Baily noted. “With the national diabetic screening service now available (in Ireland), it is likely there will be an increased pick-up of incidental melanomas, due to the large volume of posterior segments being reviewed,” she told EuroTimes. Uveal melanoma is often asymptomatic and therefore picked up during routine eye examinations, Dr Baily noted.Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.